GLP-1s and Muscle Loss - Part 2 Wegovy and Zepbound
Weight and Healthcare · Ragen Chastain
November 8, 202510m 18s
Audio is streamed directly from the publisher (api.substack.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In Part 1 we looked at an early study of GLP1 drugs and muscle loss. Today we’ll look at two more recent studies, one for Eli Lilly’s drug tirzepatide and one for Novo Nordisk’s drug semaglutide.
Get full access to Weight and Healthcare at weightandhealthcare.substack.com/subscribe